J. Patel

Targeting apoptosis in prostate cancer.

R. DiPaola, M. Rafi, J. Patel, 2001, Hematology/oncology clinics of North America.

Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma

A. Garg, A. Anand, H. Panchal, 2021, Indian Journal of Hematology and Blood Transfusion.

Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.

R. DiPaola, W. Hait, D. Toppmeyer, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer

A. Drilon, J. Berlin, D. Hyman, 2020, Zeitschrift für Gastroenterologie.

Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial.

D. Isenberg, B. Hazleman, M. Sopwith, 2002, Rheumatology.

Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available.

L. Benjamin, R. Martell, E. Chiorean, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.